187 related articles for article (PubMed ID: 28605939)
1. Real-world treatment outcomes in patients with metastatic Merkel cell carcinoma treated with chemotherapy in the USA.
Cowey CL; Mahnke L; Espirito J; Helwig C; Oksen D; Bharmal M
Future Oncol; 2017 Aug; 13(19):1699-1710. PubMed ID: 28605939
[TBL] [Abstract][Full Text] [Related]
2. Response rates and durability of chemotherapy among 62 patients with metastatic Merkel cell carcinoma.
Iyer JG; Blom A; Doumani R; Lewis C; Tarabadkar ES; Anderson A; Ma C; Bestick A; Parvathaneni U; Bhatia S; Nghiem P
Cancer Med; 2016 Sep; 5(9):2294-301. PubMed ID: 27431483
[TBL] [Abstract][Full Text] [Related]
3. Real-World Clinical Outcomes in Patients with Locally Advanced or Metastatic Merkel Cell Carcinoma Treated in U.S. Oncology Clinical Practices: Results from SPEAR-Merkel.
Bhanegaonkar A; Liu FX; Boyd M; Fulcher N; Kim R; Krulewicz S; Smith J; Cowey CL
Oncologist; 2021 Sep; 26(9):e1633-e1643. PubMed ID: 34101298
[TBL] [Abstract][Full Text] [Related]
4. Real-world clinical outcomes with first-line avelumab in locally advanced/metastatic Merkel cell carcinoma in the USA: SPEAR-Merkel.
Cowey CL; Liu FX; Kim R; Boyd M; Fulcher N; Krulewicz S; Kasturi V; Bhanegaonkar A
Future Oncol; 2021 Jun; 17(18):2339-2350. PubMed ID: 33709776
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of First-line Avelumab Treatment in Patients With Stage IV Metastatic Merkel Cell Carcinoma: A Preplanned Interim Analysis of a Clinical Trial.
D'Angelo SP; Russell J; Lebbé C; Chmielowski B; Gambichler T; Grob JJ; Kiecker F; Rabinowits G; Terheyden P; Zwiener I; Bajars M; Hennessy M; Kaufman HL
JAMA Oncol; 2018 Sep; 4(9):e180077. PubMed ID: 29566106
[TBL] [Abstract][Full Text] [Related]
6. Real-world clinical outcomes with avelumab in patients with Merkel cell carcinoma treated in the USA: a multicenter chart review study.
Bhatia S; Nghiem P; Veeranki SP; Vanegas A; Lachance K; Tachiki L; Chiu K; Boller E; Bharmal M
J Immunother Cancer; 2022 Aug; 10(8):. PubMed ID: 35981787
[TBL] [Abstract][Full Text] [Related]
7. Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial.
Kaufman HL; Russell JS; Hamid O; Bhatia S; Terheyden P; D'Angelo SP; Shih KC; Lebbé C; Milella M; Brownell I; Lewis KD; Lorch JH; von Heydebreck A; Hennessy M; Nghiem P
J Immunother Cancer; 2018 Jan; 6(1):7. PubMed ID: 29347993
[TBL] [Abstract][Full Text] [Related]
8. Clinical Benefit from Tyrosine Kinase Inhibitors in Metastatic Merkel Cell Carcinoma: A Case Series of 5 Patients.
Tarabadkar ES; Thomas H; Blom A; Parvathaneni U; Olencki T; Nghiem P; Bhatia S
Am J Case Rep; 2018 Apr; 19():505-511. PubMed ID: 29706615
[TBL] [Abstract][Full Text] [Related]
9. Cisplatin-based chemotherapy for merkel cell carcinoma of the skin.
Pectasides D; Pectasides M; Psyrri A; Koumarianou A; Xiros N; Pectasides E; Gaglia A; Lianos E; Papaxoinis G; Lampadiari V; Economopoulos T
Cancer Invest; 2006 Dec; 24(8):780-5. PubMed ID: 17162559
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy in neuroendocrine/Merkel cell carcinoma of the skin: case series and review of 204 cases.
Tai PT; Yu E; Winquist E; Hammond A; Stitt L; Tonita J; Gilchrist J
J Clin Oncol; 2000 Jun; 18(12):2493-9. PubMed ID: 10856110
[TBL] [Abstract][Full Text] [Related]
11. Patient characteristics, treatment patterns, and clinical outcomes among patients with previously treated recurrent or metastatic cervical cancer: A community oncology-based analysis.
Alholm Z; Monk BJ; Ting J; Pulgar S; Boyd M; Sudharshan L; Bains S; Nicacio L; Coleman RL
Gynecol Oncol; 2021 May; 161(2):422-428. PubMed ID: 33741208
[TBL] [Abstract][Full Text] [Related]
12. Five hundred patients with Merkel cell carcinoma evaluated at a single institution.
Fields RC; Busam KJ; Chou JF; Panageas KS; Pulitzer MP; Allen PJ; Kraus DH; Brady MS; Coit DG
Ann Surg; 2011 Sep; 254(3):465-73; discussion 473-5. PubMed ID: 21865945
[TBL] [Abstract][Full Text] [Related]
13. Systematic literature review of efficacy, safety and tolerability outcomes of chemotherapy regimens in patients with metastatic Merkel cell carcinoma.
Nghiem P; Kaufman HL; Bharmal M; Mahnke L; Phatak H; Becker JC
Future Oncol; 2017 Jun; 13(14):1263-1279. PubMed ID: 28350180
[TBL] [Abstract][Full Text] [Related]
14. Merkel cell carcinoma in Latin America: a contribution from an expanded access program for avelumab to address issues from experts' recommendations.
Munhoz RR; Cayol F; Corrales L; Gerson R; Tilli M; Barreto EO; Sánchez Castillo JO; Schmerling RA; Cinat G
Cancer Immunol Immunother; 2021 Apr; 70(4):1031-1036. PubMed ID: 33104838
[TBL] [Abstract][Full Text] [Related]
15. Further insights into the natural history and management of primary cutaneous neuroendocrine (Merkel cell) carcinoma.
Boyle F; Pendlebury S; Bell D
Int J Radiat Oncol Biol Phys; 1995 Jan; 31(2):315-23. PubMed ID: 7836085
[TBL] [Abstract][Full Text] [Related]
16. Merkel cell carcinoma: improved outcome with adjuvant radiotherapy.
Veness MJ; Perera L; McCourt J; Shannon J; Hughes TM; Morgan GJ; Gebski V
ANZ J Surg; 2005 May; 75(5):275-81. PubMed ID: 15932436
[TBL] [Abstract][Full Text] [Related]
17. Merkel cell carcinoma: report of 10 cases and review of the literature.
Akhtar S; Oza KK; Wright J
J Am Acad Dermatol; 2000 Nov; 43(5 Pt 1):755-67. PubMed ID: 11050578
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy for patients with locally advanced or metastatic Merkel cell carcinoma.
Voog E; Biron P; Martin JP; Blay JY
Cancer; 1999 Jun; 85(12):2589-95. PubMed ID: 10375107
[TBL] [Abstract][Full Text] [Related]
19. Merkel cell carcinoma of the eyelid: management and prognosis.
Herbert HM; Sun MT; Selva D; Fernando B; Saleh GM; Beaconsfield M; Collin R; Uddin J; Meligonis G; Leatherbarrow B; Ataullah S; Irion L; McLean CJ; Huilgol SC; Davis G; Sullivan TJ
JAMA Ophthalmol; 2014 Feb; 132(2):197-204. PubMed ID: 24287584
[TBL] [Abstract][Full Text] [Related]
20. Analysis of radiation therapy for the control of Merkel cell carcinoma of the head and neck based on 36 cases and a literature review.
Lawenda BD; Arnold MG; Tokarz VA; Silverstein JR; Busse PM; McIntyre JF; Deschler DG; Baldini EH; Kachnic LA
Ear Nose Throat J; 2008 Nov; 87(11):634-43. PubMed ID: 19006065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
